Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2014Clinical Cancer Research

A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

SASailyn AlfonsoHospital Oncológico Docente "Conrado Benítez García"AVAnet Valdés-ZayasCenter of Molecular Immunology (Cuba)ESEduardo R. Santiesteban

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Alfonso et al. (2014) studied this question.

synapsesocial.com/papers/6aa91b25231e8f09c2acb6c4https://doi.org/10.1158/1078-0432.ccr-13-1674
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Human antibodies reactive to N eu G c GM 3 ganglioside have cytotoxic antitumor properties2013 · 36 citations
  2. 2Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody2008 · 94 citations